27
Participants
Start Date
December 27, 2022
Primary Completion Date
July 1, 2023
Study Completion Date
July 1, 2023
EQU-001
20 mg pills of EQU-001
Matching Placebo
20 mg matching placebo pills
NYU Langone Health, New York
Comprehensive Epilepsy Center at Thomas Jefferson University, Philadelphia
Mid-Atlantic Epilepsy and Sleep Center, Bethesda
University of Virginia, Charlottesville
Sooner Clinical Research, Inc., Oklahoma City
Northwest Houston Neurology, Cypress
Consultants in Epilepsy and Neurology, PLLC, Boise
Ramban Health Care Campus, Haifa
Rabin Medical Center, Petah Tikva
Chaim Sheba Medical center, Ramat Gan
Tel Aviv Sourasky Medical Center, Tel Aviv
Hadassah Medical Center, Jerusalem
Institute of Neurology and Neurosurgery at Saint Barnabas, Livingston
Lead Sponsor
Equilibre Biopharmaceuticals B.V.
INDUSTRY